About the Company
We do not have any company description for TriSalus Life Sciences, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on TriSalus Life Sciences, Inc.
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q2 2025 Earnings Call Transcript
Q2 2025 Earnings Call Transcript August 12, 2025 TriSalus Life Sciences, Inc. misses on earnings expectations. Reported EPS is $-0.27 EPS, expectations were $-0.22. Operator: Good afternoon, and ...
TriSalus Life Sciences, Inc. (TLSI) Reports Q2 Loss, Tops Revenue Estimates
TriSalus Life Sciences, Inc. (TLSI) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to a loss of $0.21 per share a year ago.
Earnings To Watch: TriSalus Life Sciences Inc (TLSI) Reports Q2 2025 Result
TriSalus Life Sciences Inc (NASDAQ:TLSI) is set to release its Q2 2025 earnings on Aug 12, 2025. The consensus estimate for Q2 2025 revenue is $10.69 million, and the earnings are expected to come in ...
TriSalus Life Sciences, Inc. (TLSI) Q1 2024 Earnings Call Transcript
TriSalus Life Sciences, Inc. (NASDAQ: TLSI) Q1 2024 Earnings Conference Call May 15, 2024 9:00 AM ET Company Participants Jim Young – Senior Vice President-Investor Relations and Treasurer ...
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Receives $11.56 Consensus ...
TriSalus Life Sciences has a 52 week low of $3.50 and a 52 week high of $10.42. The business’s fifty day simple moving average is $5.19 and its 200 day simple moving average is $4.72.
TLSI | TriSalus Life Sciences Inc. Profile | MarketWatch
Company Profile TriSalus Life Sciences Inc. 6272 West 91st Avenue Westminster, Colorado 80031 Phone1 303 442-1222 IndustryPharmaceuticals SectorHealth Care/Life Sciences Fiscal Year-end12/2024 ...
TriSalus Life Sciences Inc (TLSI) Q2 2025 Earnings Call Highlights: Strong Sales Growth and ...
TriSalus Life Sciences Inc (TLSI) reports a 52% sales increase and successful product launches, while navigating increased expenses and strategic investments.
TriSalus Life Sciences, Inc. (TLSI) Q3 2024 Earnings Call Transcript
TriSalus Life Sciences, Inc. (NASDAQ: TLSI) Q3 2024 Earnings Conference Call November 14, 2024 9:00 AM ET Company Participants Jim Young - Senior Vice President, Investor Relations & Treasurer ...
TriSalus Life Sciences, Inc. (TLSI) Soars 6.6%: Is Further ... - Nasdaq
TriSalus Life Sciences, Inc. (TLSI) shares soared 6.6% in the last trading session to close at $5.49. The move was backed by solid volume with far more shares changing hands than in a normal session.
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q4 2023 Earnings Call ...
TriSalus Life Sciences, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning.
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q2 2024 Earnings Call ...
TriSalus Life Sciences, Inc. (NASDAQ: TLSI) Q2 2024 Earnings Call Transcript August 15, 2024 Operator: Good morning, and welcome to TriSalus Science Second Quarter 2024 Earnings Conference Call.
Similar Companies
Loading the latest forecasts...